Literature DB >> 23790341

Peripheral blood cell variations in cirrhotic portal hypertension patients with hypersplenism.

Yun-Fu Lu1, Xin-Qiu Li, Xiao-Yu Han, Xiao-Guang Gong, Shun-Wu Chang.   

Abstract

OBJECTIVE: To explore peripheral blood cell variations in hepatic cirrhosis portal hypertension patients with hypersplenism.
METHODS: Clinical data of 322 hypersplenism patients with decreased peripheral blood cells, admitted with cirrhotic portal hypertension, was retrospectively studied over the last 17 years.
RESULTS: In 64% (206/322) of patients, more than 2 kinds of blood cell were decreased, including 89 cases of pancytopenia (43.2%), 52 cases of WBC + PLT decrease (25.2%), 29 cases of RBC + PLT decrease (14.1%), and 36 cases of WBC + RBC decrease (17.5%); in 36% (116/322) of patients, single type blood cell decrease occurred, including 31 cases of PLT decrease (26.7%), 29 cases of WBC decrease (25%) and 56 cases of RBC decrease (48.3%). Of 227 routine bone marrow examinations, bone marrow hyperplasia was observed in 118 cases (52.0%), the remainder showed no hyperplasia. For the distinct scope and extent of peripheralblood cell decreases, preoperative blood component transfusions were carried out, then treated by surgery, after whole group splenectomy, the peripheral blood cell count was significantly higher (P<0.05).
CONCLUSIONS: Of portal hypertensive patients with splenomegaly and hypersplenism, 64% have simultaneous decrease in various blood cells, 36% have decrease in single type blood cells, 52% of patients have bone marrow hyperplasia. A splenectomy can significantly increase the reduction of peripheral blood cells.
Copyright © 2013 Hainan Medical College. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23790341     DOI: 10.1016/S1995-7645(13)60115-7

Source DB:  PubMed          Journal:  Asian Pac J Trop Med        ISSN: 1995-7645            Impact factor:   1.226


  13 in total

1.  Clinical application value of preoperative selective partial splenic embolization before splenectomy plus portal-azygous disconnection.

Authors:  Shengxing Zhu; Sheng Chang
Journal:  Int J Clin Exp Pathol       Date:  2015-08-01

2.  Hypersplenism: an independent risk factor for myocardial remodeling in chronic heart failure patients.

Authors:  Yong Tang; Wenbin Lu; Ziwei Zhang; Pengfei Zuo; Genshan Ma
Journal:  Int J Clin Exp Med       Date:  2015-04-15

3.  Causes of peripheral cytopenia in hepatitic cirrhosis and portal hypertensive splenomegaly.

Authors:  Yunfu Lv; Wan Yee Lau; Hongfei Wu; XiaoYu Han; Xiaoguang Gong; Ning Liu; Jie Yue; Qingqing Li; YeJuan Li; Jie Deng
Journal:  Exp Biol Med (Maywood)       Date:  2017-01-01

4.  Spleen Regulates Hematopoietic Stem/Progenitor Cell Functions Through Regulation of EGF in Cirrhotic Hypersplenism.

Authors:  Peijun Wang; Zhenzhen Li; Song Ren; Jiangwei Li; Jun Yang; Guangyao Kong; An Jiang; Zongfang Li
Journal:  Dig Dis Sci       Date:  2018-05-03       Impact factor: 3.199

5.  Partial splenic embolization combined with endoscopic therapies and NSBB decreases the variceal rebleeding rate in cirrhosis patients with hypersplenism: a multicenter randomized controlled trial.

Authors:  Yanjing Gao; Xin Sun; Anzhong Zhang; Tao Zhou; Minghui Wang; Yong Chen; Ting Zhou; Xiaoning Chen; Aiyuan Xiu; Zhi Peng; Baoquan Cheng; Xiaofeng Liu
Journal:  Hepatol Int       Date:  2021-02-27       Impact factor: 6.047

6.  Long-term efficacy of subtotal splenectomy due to portal hypertension in cirrhotic patients.

Authors:  Haibo Chu; Wei Han; Lei Wang; Yongbo Xu; Fengguo Jian; Weihua Zhang; Tao Wang; Jianhua Zhao
Journal:  BMC Surg       Date:  2015-07-24       Impact factor: 2.102

7.  Splenectomy versus Partial Splenic Embolization for Massive Splenomegaly Secondary to Hepatitis B-Related Liver Cirrhosis: A Case-Control Study.

Authors:  Shoufei Jiao; Hongxing Chen; Youlong Wang; Jiye Zhu; Jingwang Tan; Jie Gao
Journal:  Gastroenterol Res Pract       Date:  2016-06-22       Impact factor: 2.260

8.  Combination of PCT, sNFI and dCHC for the diagnosis of ascites infection in cirrhotic patients.

Authors:  Han Wang; Yan Li; Fangfang Zhang; Ning Yang; Na Xie; Yuanli Mao; Boan Li
Journal:  BMC Infect Dis       Date:  2018-08-10       Impact factor: 3.090

9.  Distribution characteristics of cells in splenomegaly due to hepatitis B-related cirrhotic portal hypertension and their clinical importance.

Authors:  Xiaoyu Han; Yunfu Lv; Yejuan Li; Jie Deng; Qingan Qiu; Ning Liu; Shuya Zhao; Caixian Liao
Journal:  J Int Med Res       Date:  2018-05-20       Impact factor: 1.671

10.  Host Immunological Effects of Partial Splenic Embolization in Patients with Liver Cirrhosis.

Authors:  Yasushi Matsukiyo; Hidenari Nagai; Teppei Matsui; Yoshinori Igarashi
Journal:  J Immunol Res       Date:  2018-07-15       Impact factor: 4.818

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.